ISSN: 2581-5407 Clinical Group

Global Journal of Cancer Therapy  Open Access

    Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesNo
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Permanent article identifierDOI (Digital Object Identifier)We provide DOI to all published papers. It'll facilitate for higher citation and classification.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editor-in-Chief

    M.Waheed Roomi

    M.Waheed Roomi
    Dr. Rath Research Institute
    1260 Memorex Drive, Santa Clara, USA
    Email: w.roomi@drrath.com
    Tel: (408)730-4481
    Fax: (408) 588-7174

    More Info.

    Tsuyoshi Shirakawa

    Tsuyoshi Shirakawa
    Kyushu University, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
    Email: t-w-r@intmed1.med.kyushu-u.ac.jp
    Tel: +81-92-661-5395
    Fax: +81-955-70-1511

    More Info.


    Welcome from the desk of

    Dr. Tsuyoshi Shirakawa, MD., Executive Editor

    Welcome to our website! I am very happy for your visit.

    Global Journal of Cancer Therapy reports both clinical and experimental results related to cancer, and is using online review and Editorial Manager System for quality review process. The Journal invites all type of clinical and medical case reports, case studies, basic researches, clinical images, pharmacology and nursing, as it were, total oncology. The goal of us is to keep a record of the state-of-the-art research or case report and to promote study, research and improvement within its various specialties, then to develop total oncology.

    We believe your expertise knowledge will help in the growth of the journal and as well help many budding research scientists all around the world. Your article will be a key insight into real medical cases that are essential for physicians, and may ultimately help to improve patient outcomes.

    Editorial Board

    Wei Du
    Hematology and Cancer Biology
    Cincinnati Childrens Hospital Medical Center
    USA
    Wei.Du@cchmc.org
    GJCT

    Research Interest: Stem Cell Biology And Pathophysiology Of Bone Marrow Failure And Leukemia; Identifying And Targeting The Alternative Oxidative DNA-Damage Response Pathways Required For Cancer Progression; The Role Of A Major Proliferating Protein, Nucleophosmin (NPM) In Cancer Development


    More Info.
    Zhu Shu
    Yale University
    USA
    shu.zhu@yale.edu
    GJCT

    Research Interest: To Study How Our Immune Systems Recognize “Self” (The Host) Or “Non-¬‐Self” (Foreign Material) Antigens, And How The Break Of These Processes Leads To The Consequent Disease Pathology, Including Infectious Diseases And Autoimmune Diseases.


    More Info.
    Karim Essani
    Professor
    Department of Biological Sciences
    Western Michigan University
    USA
    karim.essani@wmich.edu
    GJCT
    Research Interest: Virus, Poxvirus, Tanapoxvirus, Virotherapy, Oncolytic viruses
    More Info.
    Xingding Zhang
    Assistant Professor
    Diagnosis and Nanomedicine Engineering Technology Center
    China
    ading5@hotmail.com
    GJCT

    Research Interest: Autophagy and Apoptosis


    More Info.
    Jinbo Gao
    Department of Gastrointestinal Surgery
    Huazhong University of Science and Technology
    China
    gaojinbo@163.com
    GJCT

    Research Interest:  Gastric Cancer; Colon Cancer; Rectal Cancer; Interferon Regulatory Factor-1 (IRF-1); Chemotherapy; Drug Resistance; Telomerase

    More Info.
    Stefania Staibano
    Professor
    Department of Pathology
    University of Naples Federico II
    Italy
    staibano@unina.it
    GJCT

    Research Interest: Head And Neck Pathology Section At The Department Of Surgical Pathology


    More Info.
    Hikmat N Abdel-Razeq
    Deputy Director General
    King Hussein Cancer Center
    University of Jordan
    Jordan
    habdelrazeq@KHCC.JO
    GJCT

    Research Interest: Clinical Oncology

    More Info.
    Zbigniew Antosz
    Department of Pathology
    Regional Specialistic Hospital
    Poland
    antosz@mp.pl
    GJCT

    Research Interest: Histopathology, Anatomical pathology, Experimental oncology


    More Info.
    Andrey Akopov
    Professor
    Pavlov First State Medical University
    Russia
    akopovand@mail.ru
    GJCT

    Research Interest: Lung Cancer, Surgery, Neoadjuvant Therapy, Photodynamic Therapy, Targeted Therapy, Malignant Pleural Effusion, Endobronchial Therapy.


    More Info.
    Maryam Azimi Mohammadabadi
    Department of Immunology
    Tehran University of Medical Science
    Iran
    m-azimim@razi.tums.ac.ir
    GJCT

    Research Interest: Potential Therapeutic Applications of Arteether, a Semi-Synthetized Derivative of Artemisinin on a Murine Model of Breast Cancer. As a Result, I Have Got Some Experience Atan Area of Tumor Immunology/Immunotherapynamed "Chemoimmunotherapy". Chemoimmunotherapy is an Approach for the Treatment of Cancers in Whichthe Focus is to enhance the Efficacy of chemotherapeutic Agents by Concomitant Application of Compounds with Immunomodulatory Properties. Besides my Thesis Work, I Managed to Do a Course in Cellular Immunology with Professor Hassan, One of the Well-Knownimmunologists in Iran, so that i could also Work on Cellular Immunology Aspects of Tumors. Moreover, Considering the Reported Associations between Molecular Players such as CTLA-4, PDL-1 and also Different Micrornas in Tumor Progression, i am Currently Planning to further Study these Associations in order to improve the Efficacy of Tumor Immunotherapy

    More Info.
    Edgar Selzer
    Professor
    Landesklinikum Wiener Neustadt
    Medical University Vienna
    Austria
    eselze82@gmail.com
    GJCT

    Research Interest:Oncology, Radiotherapy, Radiobiology, Head And Neck Cancer; Anti-Cancer Drug Research


    More Info.
    Rajeev Shrivastava
    Department of Radiation Oncology
    Aditya Birla Memorial Hospital
    India
    dr_shriraj@yahoo.co.in
    GJCT

    Research Interest: Carcinoma Lung, Breast and Cervix

    More Info.
    Vessela Vassileva
    Research Associate
    Department of Surgery & Cancer
    UCL Cancer Institute
    UK
    vessie_vassileva@hotmail.com
    GJCT

    Research Interest: Research Interests And Career Have Focused On The Pathobiology And Treatment Of Cancer – From Identifying Key Genes And Molecular Pathways Involved In The Initiation, Development And Progression Of Cancer To Identifying Novel Treatments, Causes Of Resistance To Therapy In Solid Tumours And Strategies To Overcome Treatment Failure. She Has Wide Expertise In Oncology And Innovative Drug Development Gained From Her Academic, Publishing And Regulatory Experience.


    More Info.
    Letizia Polito
    Assistant Professor
    Department of Experimental
    University of Bologna
    Italy
    letizia.polito@unibo.it
    GJCT

    Research Interest: The Scientific Activity Is Focused On Two Main Topics Concerning The Study Of Plant Toxins Known As Ribosome-Inactivating Proteins (Rips), And The Design And Testing In Vitro And In Vivo Of Immunotoxins For The Experimental Therapy Of Tumors And For The Immunosuppression.


    More Info.
    Yatendra Kumar Satija
    Yatendra Kumar Satija Molecular Oncology Lab
    National Institute of Immunology
    USA
    yksatija@gmail.com
    GJCT

    Research Interest: Haematology Including Body Fluids, Clinical Biochemistry, Blood Bank, Clinical Microbiology, Cyto- Histopathology

    More Info.
    View more
    mendeley

    Total Oncology is necessary for Japanese new era CrossMark

    DOI Logo 10.17352/2581-5407.000022

    Published On: October 13, 2018 | Pages: 001 - 003

    Author(s): Tsuyoshi Shirakawa*
    Abstract View Full Article View Get Citation
    mendeley

    Video Endoscopic Inguinal Lymphadenectomy: Refi ning surgical technique after ten years experience CrossMark

    DOI Logo 10.17352/gjct.000021

    Published On: December 30, 2017 | Pages: 034 - 037

    Author(s): Marcos Tobias-Machado, Pericles Rios Auad*, Victor Corona, Igor Silva, Oseas de Castro Neves, Eliney Ferreira Faria, Pablo Matos, Alexandre Cesar Santos, Roberto Machado, Aurus Dourado and Hamilton de Campos Zampolli
    Abstract View Full Article View Get Citation
    mendeley

    Role of tumor heterogeneity in drug resistance CrossMark

    DOI Logo 10.17352/gjct.000020

    Published On: July 20, 2017 | Pages: 032 - 033

    Author(s): Dhruv Kumar*
    Abstract View Full Article View Get Citation
    mendeley

    MEK Inhibitors in Combination with Immune Checkpoint Inhibition: Should we be Chasing Colorectal Cancer or the KRAS Mutant Cancer CrossMark

    DOI Logo 10.17352/gjct.000019

    Published On: May 26, 2017 | Pages: 030 - 031

    Author(s): Julius Strauss*
    Abstract View Full Article View Get Citation
    mendeley

    Angiosarcoma of the Scalp and Face: A Hard to Treat Tumor CrossMark

    DOI Logo 10.17352/gjct.000018

    Published On: April 15, 2017 | Pages: 026 - 029

    Author(s): Jmour Omar*, Kochbati Lotfi , Ghith Sahar and Benna Farouk
    Abstract View Full Article View Get Citation
    mendeley

    The Promise of Disease Management in Greece CrossMark

    DOI Logo 10.17352/gjct.000017

    Published On: March 30, 2017 | Pages: 018 - 025

    Author(s): Konstantinos Stamatiou, Richard Lacroix, Eleni Almpani, Konstantinos Katsanos, Georgios Tzitzikos and Maria Saridi*
    Abstract View Full Article View Get Citation
    mendeley

    Abrikossoff’s Tumour Mimicking a Neoplastic Tumour of the Breast: A Case Report CrossMark

    DOI Logo 10.17352/gjct.000016

    Published On: March 20, 2017 | Pages: 015 - 017

    Author(s): Alassiri A*, Al Ali A, Vaysse C, Escourrou G, Vinet B and Rimailho J
    Abstract View Full Article View Get Citation
    mendeley

    The Role of Decavanadate in Anti- Tumour Activity CrossMark

    DOI Logo 10.17352/gjct.000015

    Published On: March 11, 2017 | Pages: 012 - 014

    Author(s): M Aureliano*
    Abstract View Full Article View Get Citation
    mendeley

    Diagnosing HPV-Related Oropharyngeal Cancers: The Need to Speak a Common Language CrossMark

    DOI Logo 10.17352/gjct.000014

    Published On: March 07, 2017 | Pages: 008 - 011

    Author(s): Daniela Russo#, Francesco Merolla#, Gennaro Ilardi*, Silvia Varricchio, Danila Caroppo, Virginia Napolitano, Massimo Mascolo and Stefania Staibano
    Abstract View Full Article View Get Citation
    mendeley

    Is it Time for the Introduction of Colostomy Free Survival in Rectal Cancer Patients CrossMark

    DOI Logo 10.17352/gjct.000013

    Published On: February 28, 2017 | Pages: 004 - 007

    Author(s): Mostafa El Haddad*
    Abstract View Full Article View Get Citation

     

    Clients' voices

    Readmore

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on GJCT